STAT annotates emails physician Kerry Kennedy Meltzer received from her uncle, Robert F. Kennedy Jr., commenting on the ...
A big step forward in COVID-19 treatment and a breakthrough for a Florida-based nonprofit blood center serving the southeast. OneBlood just became the first blood center to get full FDA approval to ...
In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...
Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.
The collapse reflects a widespread and mounting distrust of public health authorities, and the reason for that distrust is no mystery.
Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.
Friday marked five years since a suburban hospital announced it was treating the first confirmed COVID-19 patient in Illinois ...
Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.
An England-wide study of over 58 million people has identified eight rare diseases that carry significantly increased risks ...